EU Commercialization Strategies
Summit Co-Chair and Managing Director for InterWest Partners, Gilbert Kliman MD, captures the audience’s thoughts on commercialization strategies in Europe through a series of live polling questions. Also gaining the expert opinions of panelists, Laurent Attias, David Muller, David E.I. Pyott, Jim Mazzo and Andy Corley, Gil compares the who, what and where questions that will bring the most value to companies entering and currently established in Europe.
Gilbert H. Kliman, MD
Dr. Gil Kliman leads the medical device investment team at InterWest Partners and invests in a broad array of healthcare opportunities, with a special interest in ophthalmology and digital health.
Laurent Attias is Senior Vice President, Head of Strategy, BD&L and M&A. In this role, Mr. Attias leads the development of Alcon’s long-term strategic plan.
David Muller, PhD
Dr. Muller recognized the potential of using advanced methods to gently reshape the cornea and in 2007 founded Avedro, Inc., where he serves as the CEO.
David E.I. Pyott
David E.I. Pyott joined Allergan on January 1, 1998. During his tenure, Mr. Pyott has transformed Allergan from a small eye care business to a global specialty pharmaceutical and medical device company with leadership positions in six medical specialties.
Jim Mazzo is the Executive Chairman and CEO for AcuFocus. AcuFocus specializes in presbyopia correction and is known for its revolutionary KAMRA inlay which was recently FDA approved.
Andy Corley co-founded Eyeonics, Inc. in 1998. Mr. Corley spearheaded a 5-year effort to change CMS policy to allow Medicare beneficiaries a choice in their selection of intraocular lenses associated with cataract surgery.